The observations reported in this paper were made in the management of 60 patients, some of whom had been treated with various preparations of protamine-insulin since February 1936. Since August 1936, all patients in this group have received protamine-zinc-insulin. Cases of all degrees of severity have been treated and four children are included in the group. The ages of the patients vary from 8 to 76 years.
It has been felt advisable to hospitalize all patients during the first part of their treatment. The hospital stay averaged 18 days. No patient was confined to bed except for some complication. An
Learn more about subscription options.
Register Now for a free account.
PROTAMINE-ZINC-INSULIN IN DIABETES(PROTAMINE-ZINC-INSULIN IN DIABETES*). Ann Intern Med. 1938;11:1079–1991. doi: 10.1059/0003-4819-11-11-1979
Download citation file:
Published: Ann Intern Med. 1938;11(11):1079-1991.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only